Pharma rep collapses as Trump announces drug price cuts (VIDEO)

ER Editor: This is a White House comm too good to miss. Standard RT reporting below, with some interpretive tweets first. (Of course, we just wish we didn’t live in a world where idiots are getting sick with that dreadful drug Ozempic in the first place, no matter the price of it.)

Yes, they RAISED HIS FEET. Who does that? Oh, wait …

Yes, very odd LOL —

If anyone seriously believes this is Trump, Oz, RFK Jr., Uncle Tom Cobbly Pharma Exec, we have a bridge to sell you. Central casting indeed —

********

Pharma rep collapses as Trump announces drug price cuts (VIDEO)

The US president has announced a new deal that would lower the price of some weight loss medications

RT

A pharmaceutical industry representative collapsed in the Oval Office on Thursday as members of US President Donald Trump’s administration were announcing a new deal for weight-loss medications.

The man was standing behind Trump during the event when his knees appeared to suddenly buckle underneath him. According to media outlets, he was initially identified as Novo Nordisk executive Gordon Finlay. However, the Danish company, which produces Ozempic, Rybelsus, and Wegovy, later denied that it was Finlay.

Pharma rep collapses as Trump announces drug price cuts (VIDEO)

According to Fox News reporter Jacqui Heinrich, who witnessed the incident firsthand, Dr. Mehmet Oz, the administrator of the Centers for Medicare and Medicaid Services, assisted the executive as he collapsed, ensuring that he did not hit his head when he fell. Cabinet members attended to the man, propping up his legs, after reporters were escorted out of the Oval Office.

White House Press Secretary Karoline Leavitt later said “the gentleman is okay.”

Earlier in the Oval Office, Trump announced that prices of weight loss drugs like Ozempic would be “much lower.” The press conference featured executives from Novo Nordisk and another drug maker, Eli Lilly, which have worked with the administration on a deal to make weight loss medications, known as GLP-1s, more affordable.

Drugmakers will broaden access to popular obesity drugs like Ozempic, Wegovy, and Zepbound through TrumpRx, a new government website launching next year. Oral versions could start at $149 a month once cleared by the FDA. Injectable GLP-1 drugs will cost $245 a month for Medicare and Medicaid patients using them for approved conditions such as diabetes.

Source

************

Published to The Liberty Beacon from EuropeReloaded.com

••••

The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)

••••

Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.

••••

Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.

••••

Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.

Be the first to comment

Leave a Reply

Your email address will not be published.


*